Literature DB >> 16982968

Experience with surgical management of cholesteatomas.

Mohammad Ajalloueyan1.   

Abstract

OBJECTIVE: To evaluate long-term results after at least 10 years of follow-up for a common method of ear surgery for managing cholesteatomas.
METHODS: This retrospective study was performed by assessing the medical records of adult patients who underwent canal-wall-down mastoidectomy for management of cholesteatomas.
RESULTS: From January 1, 1989, through December 31, 1995, 148 patients underwent surgery for cholesteatoma. Of these, 72 (48%) were treated by using the canal-wall-down method. During follow-up (10-16 years), 5 (7%) patients underwent at least 1 revision operation. Ten years after primary surgery, 69 (96%) of the ears were dry and 55 (76%) had intact tympanic membranes with fair hearing in 30 (42%). One patient who was deaf was seen in this group of 72 patients. The recurrence rate was 7%, independent of the size of the cholesteatoma, mastoid status, or labyrinth or footplate erosion. The major predisposing factor for recurrence was retraction, especially in the posterior superior quadrant.
CONCLUSION: Our results showed that the surgical technique could be improved by using endoscopes to lower the recurrence rate and improve hearing results.

Entities:  

Mesh:

Year:  2006        PMID: 16982968     DOI: 10.1001/archotol.132.9.931

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  11 in total

1.  Middle ear cholesteatoma in 11 dogs.

Authors:  Valentina Greci; Olga Travetti; Mauro Di Giancamillo; Rocco Lombardo; Chiara Giudice; Barbara Banco; Carlo M Mortellaro
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

2.  Ossicular chain status in chronic suppurative otitis media in adults.

Authors:  Saurabh Varshney; Ashutosh Nangia; S S Bist; R K Singh; N Gupta; S Bhagat
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-11

Review 3.  The utility of diffusion-weighted imaging for cholesteatoma evaluation.

Authors:  K M Schwartz; J I Lane; B D Bolster; B A Neff
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-20       Impact factor: 3.825

4.  The diagnostic accuracy of non-echo-planar diffusion-weighted imaging in the detection of residual and/or recurrent cholesteatoma of the temporal bone.

Authors:  M H G Dremmen; P A M Hofman; J R Hof; R J Stokroos; A A Postma
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

5.  Surgical treatment of middle ear cholesteatoma using an oral approach in 2 dogs.

Authors:  Kae Shigihara; Naoko Yayoshi; Harumi Sawada; Yutaka Momota; Yasushi Hara
Journal:  Can Vet J       Date:  2022-04       Impact factor: 1.075

6.  A comparison of three MDCT post-processing protocols: preoperative assessment of the ossicular chain in otitis media.

Authors:  Li-chun Zhang; Busheng Tong; Zheng-min Wang; Yan Sha; Fang Zhang; Zheng Lao; Tian-yu Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-10       Impact factor: 2.503

7.  Surgical results of retrograde mastoidectomy with primary reconstruction of the ear canal and mastoid cavity.

Authors:  Chao-Yin Kuo; Bor-Rong Huang; Hsin-Chien Chen; Cheng-Ping Shih; Wei-Kang Chang; Yang-Lien Tsai; Yuan-Yung Lin; Wan-Chun Tsai; Chih-Hung Wang
Journal:  Biomed Res Int       Date:  2015-03-15       Impact factor: 3.411

8.  Is There A Systemıc Inflammatory Effect of Cholesteatoma?

Authors:  M Mustafa Kılıçkaya; Giray Aynali; Mustafa Tuz; Özkan Bagcı
Journal:  Int Arch Otorhinolaryngol       Date:  2016-06-06

9.  Cost-comparison analysis of diffusion weighted magnetic resonance imaging (DWMRI) versus second look surgery for the detection of residual and recurrent cholesteatoma.

Authors:  David L Choi; Michael K Gupta; Ryan Rebello; Jason D Archibald
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-11-07

10.  The Relationship between the M1/M2 Macrophage Polarization and the Degree of Ossicular Erosion in Human Acquired Cholesteatoma: An Immunohistochemical Study.

Authors:  Mohamed Bassiouni; Philipp Arens; Samira Ira Zabaneh; Heidi Olze; David Horst; Florian Roßner
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.